Skip to main content
Log in

Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

To determine the association between device-determined diagnostic indices, including intrathoracic impedance, and heart failure (HF) hospitalization.

Methods

Clinical and device diagnostic data of 558 HF patients indicated for CRT-D therapy (In Sync Sentry, Medtronic Inc.) were prospectively collected from 34 centers. Device-recorded intrathoracic impedance fluid index threshold crossing event (TCE), mean activity counts, tachyarrhythmia events, night heart rate (NHR) and heart rate variability (HRV) were compared within patients with vs. without documented HF hospitalization.

Results

Mean follow-up was 326 ± 216 days. Patients hospitalized for HF had significantly higher rates of TCE, a higher percentage of days with the thoracic impedance fluid index above the programmed threshold, a higher percentage of days with low activity, with low HRV or with high NHR.

Multivariate analysis showed that TCE resulted in a 36% increased probability of HF hospitalization. Both TCE duration and patient activity were also significantly associated with hospitalization. Kaplan Meier analysis indicated that patients with more TCE events were significantly more likely to be hospitalized (log rank test, p = 0.005).

Conclusions

Decreased intrathoracic impedance, low patient activity and low HRV were all independently associated with increased risk for HF hospitalization in HF patients treated with resynchronization therapy. Device-derived diagnostic data may provide valuable and reliable indices for the prognostic stratification of HF patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adamson, P. B., Smith, A. L., Abraham, W. T., Kleckner, K. J., Stadler, R. W., Shih, A., et al. (2004). Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation, 110(16), 2389–2394.

    Article  PubMed  Google Scholar 

  2. Vollmann, D., Nagele, H., Schauerte, P., Wiegand, U., Butter, C., Zanotto, G., et al. (2007). Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. European Heart Journal, 28(15), 1835–1840.

    Article  PubMed  Google Scholar 

  3. Andriulli, J., Coles, J., & Hettrick, D. A. (2008). Association between decreased intra-thoracic impedance and ventricular tachyarrhythmias. International Journal of Cardiology, 123(3), 333–334.

    Article  PubMed  Google Scholar 

  4. Yu, C. M., Wang, L., Chau, E., Chan, R. H., Kong, S. L., Tang, M. O., et al. (2005). Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation, 112(6), 841–848.

    Article  PubMed  Google Scholar 

  5. Matsushita, K., Ishikawa, T., Sumita, S., Kobayashi, T., Ogawa, H., Inoue, N., et al. (2006). Daily shock impedance measured by implantable cardioverter defibrillator is useful in the management of congestive heart failure. Circulation Journal, 70(11), 1462–1465.

    Article  PubMed  Google Scholar 

  6. Maines, M., Catanzariti, D., Cemin, C., Vaccarini, C., & Vergara, G. (2007). Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study. Journal of Interventional Cardiac Electrophysiology, 19(3), 201–207.

    Article  PubMed  Google Scholar 

  7. Luthje, L., Vollmann, D., Drescher, T., Schott, P., Zenker, D., Hasenfubeta, G., et al. (2007). Intrathoracic impedance monitoring to detect chronic heart failure deterioration: Relationship to changes in NT-proBNP. European Journal of Heart Failure, 9(6–7), 716–722.

    Article  PubMed  Google Scholar 

  8. Heist, E. K., & Ruskin, J. N. (2006). Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Progress in Cardiovascular Diseases, 48(4), 256–269.

    Article  PubMed  Google Scholar 

  9. Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., Andrews, M. L., & Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346(12), 877–883.

    Article  PubMed  Google Scholar 

  10. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352(3), 225–237.

    Article  PubMed  CAS  Google Scholar 

  11. Wilkoff, B. L., Kuhlkamp, V., Volosin, K., Ellenbogen, K., Waldecker, B., Kacet, S., et al. (2001). Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: results and technical considerations. Circulation, 103(3), 381–386.

    PubMed  CAS  Google Scholar 

  12. Page, E., Cazeau, S., Ritter, P., Galley, D., & Casset, C. (2007). Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace, 9(8), 687–693.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Clinical Service Team of Medtronic Italy for the Clinical Service project organization and management.

Disclosures

Annamaria Varbaro, Alessandra Denaro, S. Sarkar, D.A. Hettrick are employees of Medtronic, Inc.

Conflict of interest statement

No other conflict of interest exists.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Giovanni B. Perego.

Appendix

Appendix

1.1 List of participating centers and physicians

L. Tavazzi,, M. Landolina, R. Rordorf, Policlinico San Matteo—Pavia; M. Lunati, M. Frigerio, F. Oliva, Ospedale Niguarda Ca Granda—Milano; G. Vergara, M. Maines, Ospedale Santa Maria Del Carmine - Rovereto; C. Vassanelli, G. Zanotto, Ospedale Civile Maggiore di Borgo Trento –Verona; G. Lonardi, E. Visentin, Ospedale Mater Salutis di Legnago—Legnago; G. Perego, R. Brambilla, Ist. Auxologico Italiano-Ospedale S.Luca—Milano; M. Santini, R. Ricci, Ospedale San Filippo Neri—Roma; G. Speca, T. Agricola, Ospedale Civile G. Mazzini—Teramo; M.Cassese, S. Iacopino, S. Anna Hospital—Catanzaro; A. Proclemer, D. Facchin, Az. Ospedaliera S.Maria della Misericordia—Udine; P. Ravazzi, P. Diotallevi, Ospedale SS. Antonio e Biagio—Alessandria; R. Ometto, C. Bonanno, ULSS N.6 S. Bortolo—Vicenza; W. Rauhe, F. Pescoller, Ospedale Regionale San Maurizio—Bolzano; M. Gasparini, C. Ceriotti, F. Regoli, Instituto Clinico Humanitas—Rozzano (MI); M. Sassara, F. Turreni, Ospedale Belcolle—Viterbo; C. Pappone, G. Paglino, Ospedale San Raffaele—Milano; M. Bernasconi, G. Guenzati, Ospedale San Carlo Borromeo—Milano; L. Padeletti, P. Pieragnoli, Azienda Ospedaliera Careggi—Firenze; F.Gaita, M. Bocchiardo, M. Scaglione, Ospedale Civile—Asti; A. Curnis, L. Bontempi, Azienza Ospedaliera Spedali Civili—Brescia; G. Botto, M. Luzi, Ospedale S.Anna—Como; C. Perrone, A. Zorzi, Ospedale Civile - Arzignano; G. Mantovani, P. Bertocchi, Ospedale di Circolo - Desio (MI); R. Massa, P. Golzio, C. Amellone, Az. Osp. Molinette S.Giovanni Battista—Torino; A. Gavazzi, F. Cantù, M. Senni, Ospedali Riuniti—Bergamo; A. Sorgato, M. Pezzali, Osp. S. Orsola-Fatebenefratelli—Brescia; G. Capella, R. Fornerone, Ospedale Fatebenefratelli e Oftalmico—Milano; M. Pasqualini, D. Pozzetti, Azienda Ospedaliera Carlo Poma Pieve di Coriano; S. Lombroso, E. Petrucci, Ospedale di Circolo - Busto Arsizio; E. Di Girolamo, P. Sabatini, Ospedale SS. Annunziata—Chieti; P. Spirito, D. Molini, Ente Ospedaliero Ospedali Galliera—Genova; P. Gelmini, T. Bignotti, Ospedale di Desenzano - Desenzano del Garda; G. Senatore, G. Trapani, M. Giuggia, Presidio Ospedaliero Riunito—Ciriè; M. Zanetta, A. Perucca, U. Parravicini, Presidio Ospedaliero SS. Trinita—Borgomanero

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perego, G.B., Landolina, M., Vergara, G. et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol 23, 235–242 (2008). https://doi.org/10.1007/s10840-008-9303-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-008-9303-5

Keywords

Navigation